Table 3

Adverse outcomes of live birth fetuses

pSS (n=128)Controls (n=316)Adjusted OR95% CIP value
Caesarean section*94 (78.44%)134 (42.41%)3.627(2.172 to 6.059)<0.001
Premature birth*17 (13.28%)16 (5.06%)2.227(0.623 to 7.956)0.218
 Gestational age (day)†240.07±17.80240.31±17.23
 Induced premature births14 (10.94%)11 (3.48%)
Underweight*14 (10.94%)13 (4.11%)0.767(0.160 to 3.676)0.740
IUGR/SGA*3 (2.34%)4 (1.27%)1.561(0.152 to 16.031)0.708
Postpartum intrauterine infection*3 (2.34%)2 (0.63%)11.187(1.025 to 122.123)0.048
Postpartum haemorrhage*5 (3.91%)8 (2.53%)0.780(0.185 to 3.286)0.735
Neonatal asphyxia*3 (2.34%)10 (3.16%)0.243(0.041 to 1.450)0.121
Intrauterine distress*16 (12.50%)23 (7.28%)1.225(0.515 to 2.910)0.646
Neonatal brain injury*11 (8.59%)19 (6.01%)1.009(0.327 to 3.114)0.988
Superficial morphological malformation*1 (0.79%)2 (0.63%)0.684(0.048 to 9.746)0.779
Cardiac abnormalities*35 (27.34%)38 (12.03%)3.121(1.333 to 7.307)0.009
 Elevated cardiac enzymes25 (19.53%)34 (10.76%)
 Atrial/ ventricular septal defects17 (13.28%)5 (1.58%)
 CHB0 (0%)0 (0%)
 Pulmonary hypertension1 (0.79%)1 (0.32%)
 Bovine aortic arch1 (0.79%)0 (0%)
Neonatal infection*23 (17.97%)31 (9.81%)1.030(0.420 to 2.527)0.949
Neonatal acidosis*2 (1.56%)5 (1.58%)0.535(0.075 to 3.824)0.533
Electrolyte disorder of newborn*1 (0.79%)2 (0.63%)2.193(0.103 to 46.684)0.615
Neonatal jaundice*14 (10.94%)21 (6.65%)1.330(0.555 to 3.185)0.522
Neonatal hospital admission*45 (35.16%)66 (20.89%)1.132(0.489 to 2.620)0.772
  • Data were analysed by generalised linear regression method logistic.

  • *Number with the percentages between brackets.

  • †Mean±SD.

  • CHB, complete heart block; IUGR/SGA, intrauterine growth restriction/small for gestational age; n, number of deliveries.